Results for amplify translation from Maltese to English

l-istudju amplify
amplify study

l-istudju amplify-ext
amplify-ext study

tabella 10: riżultati tal-effikaċja fl-istudju amplify
table 10: efficacy results in the amplify study

tabella 10: riżultati tal-effikaċja fl-istudju amplify-ext
table 10: efficacy results in the amplify-ext study

tabella 11: riżultati tal-Ħruġ ta’ demm fl-istudju amplify-ext
table 11: bleeding results in the amplify-ext study

minn dawn, 836 pazjent (33.7%) ipparteċipaw fl-istudju amplify qabel ma rreġistraw fl-istudju amplify-ext.
of these, 836 patients (33.7%) participated in the amplify study prior to enrollment in the amplify-ext study.

fl-istudju amplify, total ta’ 5,395 pazjent intgħażlu b’mod każwali għat-trattament b’apixaban 10 mg darbtejn kuljum mill-ħalq għal 7 ijiem segwit minn apixaban 5 mg darbtejn kuljum mill-ħalq għal 6 xhur, jew enoxaparin 1 mg/kg darbtejn kuljum taħt il-ġilda għal mill-inqas 5 ijiem (sa inr 2) u warfarin (medda ta’ mira inr ta’ 2.0-3.0) mill-ħalq għal 6 xhur.
in the amplify study a total of 5,395 patients were randomised to treatment with apixaban 10 mg twice daily orally for 7 days followed by apixaban 5 mg twice daily orally for 6 months, or enoxaparin 1 mg/kg twice daily subcutaneously for at least 5 days (until inr 2) and warfarin (target inr range 2.0-3.0) orally for 6 months.